Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

New York State Psychiatric Institute, New York

The Medical Research Network, LLC, New York

Global Medical Institutes, LLC, Scranton Medical Institute, Moosic

CBH Health, LLC, Gaithersburg

Sheppard Pratt Health System, Baltimore

Pharmasite Research, Inc, Pikesville

Psych Atlanta, Atlanta

Clinical Neurosciecne Solutions, Inc. dba CNS Healthcare, Orlando

APG Research, LLC, Orlando

DMI Health Care Group, Inc, Tampa

Meridien Research/Accel Research, Tampa

Insight Clinical Trials, LLC, Beachwood

Neuro-Behaviroral Clinical Research, Inc., North Canton

University of Minnesota, Minneapolis

Uptown Research Institute, LLC, Chicago

Washington University School of Medicine, St Louis

Midwest Research Group, Saint Charles

University of Missouri, Columbia

Alivation Research, LLC., Lincoln

Rivus Wellness & Research Institute, Oklahoma City

UT Health Science Center at Houston (UTHSC-H), Houston

Cedar Clinical Research, Draper

University of Arizona College of Medicine - Tuscon, Tuscon

California Center for Psychedelic Therapy, Los Angeles

CalNeuro Research Group, Inc, Los Angeles

Clarity Clinical Research, LLC, Los Angeles

ProScience Research Group, Culver City

Kadima Neuropsychiatry Institute, La Jolla

University California San Diego, La Jolla

Artemis Institute for Clinical Research, San Diego

Collaborative Neuroscience Network, LLC, Garden Grove

ATP Clinical Research, Inc., Orange

ASCLEPES Research Centers, Thousand Oaks

Stanford University, Stanford

Lumos Clinical Research Center, San Jose

Core Clinical Research, Everett

Comprehensive Psychiatric Care, Norwich

Emory University, Atlanta

University of Massachusetts Medical School, North Worcester

Bio Behavioral Health, Toms River